№ lp_1_2_14232
File format: docx
Character count: 19710
File size: 117 KB
This guideline outlines management strategies to minimize clinical risks for women with obesity during pregnancy, labour, birth, and the postnatal period.
Year:
2023
Region / City:
Canberra
Topic:
Obesity and its impact on pregnancy and childbirth
Document Type:
Guideline
Organization:
Canberra Health Services
Author:
Not specified
Target Audience:
Medical Officers, Registered Midwives, Students under direct supervision
Effective Period:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2022
Region / City:
United Kingdom
Topic:
Postnatal care
Document type:
Consultation summary report
Organization:
National Institute for Health and Care Excellence (NICE)
Author:
NICE Quality Standards Team
Target audience:
Healthcare professionals, service providers, stakeholders
Period of validity:
2022-2023
Approval date:
12 July 2022
Date of changes:
N/A
Year:
2017
Region / City:
United Kingdom
Document Type:
Formulary Application
Department:
Medicines Committee / Gynaecology
Applicant:
Consultant (name not specified)
Speciality:
Gynaecology
Intended Use:
PMS, postnatal depression, perimenopause in patients with progestogen/progesterone intolerance
Dosage Form:
Vaginal capsules 200mg
Regulatory Status:
Off-label use
Estimated Patient Numbers:
Not specified
Estimated Cost:
£21.00 per 21 vaginal capsules
Supporting Evidence:
Randomised controlled trials and peer-reviewed publications
Approval Required By:
Divisional Medical Director, Lead Directorate Pharmacist
Signatures:
Applicant, Divisional Medical Director, Lead Directorate Pharmacist
Year:
2017
Region / City:
International
Theme:
Preterm infant growth standards, international health standards
Document type:
Project protocol
Organization:
International Preterm Postnatal Growth Standards Consortium
Author:
José Villar, Ann Lambert, Francesca Giuliani, Leila Cheikh Ismail, Carl Britto, Stephen Kennedy
Target audience:
Healthcare professionals working with preterm infants
Period of validity:
Ongoing
Approval date:
August 2017
Modification date:
N/A
Year:
2023
Region / City:
Bono East Region, Nkoranza South Municipality
Topic:
Supervised and Unsupervised Delivery
Document Type:
Dissertation
Organization / Institution:
Catholic University of Ghana, Fiapre
Author:
Felicia Ainoo
Target Audience:
Researchers, healthcare professionals, policy makers
Period of Validity:
N/A
Approval Date:
28/03/2022
Date of Changes:
N/A
Year:
2022
Region / city:
Wellington, New Zealand
Topic:
Obesity trends, Health Survey, General Practice Data
Document type:
Report
Organization / institution:
Ministry of Health
Authors:
Carlos Barroso Silva, Chloe Lynch, Maria Turley, Steven Johnston
Target audience:
Researchers, Health professionals, Policymakers
Period of validity:
2021/22
Approval date:
November 2022
Date of changes:
None mentioned
Year:
2016
Region / City:
United Kingdom
Theme:
Childhood obesity
Document Type:
Invitation to Tender
Organization:
Department of Health
Author:
Secretary of State for Health
Target Audience:
Tenderers
Period of Action:
1st June 2016
Approval Date:
18th May 2016
Modification Date:
Not specified
Contextual description:
This is an invitation to tender document for the provision of digital content on childhood obesity, outlining the tender process, requirements, and deadlines for potential bidders.
Note:
Year
Region / City:
Chinle, AZ
Topic:
Obesity, Community Health
Document Type:
Worksheet
Author:
McKenzie & Pinger
Target Audience:
Public health professionals, community health workers
Year:
2025
Region / City:
United Kingdom
Topic:
Obesity Management, Health Criteria
Document Type:
Referral Form
Organization / Institution:
NHS
Author:
N/A
Target Audience:
General Practitioners, Healthcare Providers
Validity Period:
N/A
Approval Date:
2025-10-19
Date of Changes:
N/A
Year:
2025
Region / city:
United Kingdom
Topic:
Obesity management, Eligibility criteria
Document type:
Referral form
Organization:
NHS
Author:
NHS
Target audience:
Healthcare professionals, General practitioners
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Year:
2023
Region / City:
England
Topic:
Healthcare, Quality and Outcomes Framework (QOF)
Document Type:
Business Rules
Organization / Institution:
NHS England
Author:
General Practice Specification and Extraction Service (GPSES)
Target Audience:
GP system suppliers, healthcare providers
Period of validity:
2023–2024
Approval Date:
01/04/2023
Date of Changes:
30/05/2023
Contextual description:
Business rules document for NHS England GPES, detailing technical specifications and datasets for the Quality and Outcomes Framework related to obesity.
Year:
2025
Region / City:
Louisiana
Theme:
Nutrition, Obesity, Metabolic Health
Document Type:
Grant Application Guidelines
Organization:
Pennington Biomedical Research Center
Author:
Not specified
Target Audience:
Early-stage scientists, multidisciplinary teams, post-doctoral fellows
Period of Validity:
2025
Approval Date:
Not specified
Date of Changes:
Not specified
Note:
Year
Document Type:
Conference Schedule
Target Audience:
Healthcare professionals, Nurse Practitioners
Year:
2018-2019
Region / City:
Beirut, Lebanon
Topic:
Obesity, Type 2 Diabetes, Cardiometabolic Risk Factors
Document Type:
Research Article
Institution:
Hôtel-Dieu de France Hospital, Faculty of Medicine, Saint-Joseph University
Authors:
Isabelle Jambart, Ghassan Sleilaty, Sélim Jambart, Rita Medlej, Georges Halaby, Chawki Atallah, Marie-Hélène Gannagé-Yared, Georges Hajje
Target Audience:
Healthcare professionals, researchers
Study Period:
December 2018 - December 2019
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2022
Region / City:
Queensland
Theme:
Obesity prevention, health policy
Document type:
Strategy, Action Plan
Organization / Institution:
Health and Wellbeing Queensland
Author:
Health and Wellbeing Queensland
Target audience:
Government, health professionals, community organizations, stakeholders in obesity prevention
Period of validity:
2023-2032
Approval date:
4 March 2022
Date of changes:
N/A
Note:
Description
Year:
2016
Region / City:
Hong Kong
Topic:
Obesity
Document Type:
Assessment Task
Author:
Department of Health of Hong Kong Government
Target Audience:
Senior secondary students
Period of Action:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2009
Region / City:
United States
Topic:
Obesity, Health, Food Consumption
Document Type:
Report
Organization / Institution:
University of Tennessee, Agricultural Policy Analysis Center
Author:
Daryll E. Ray, Harwood D. Schaffer
Target Audience:
General Public, Policymakers
Action Period:
Ongoing
Approval Date:
Not specified
Modification Date:
Not specified
This document presents an analysis of the obesity epidemic in the United States, exploring two distinct approaches to addressing the crisis:
a government policy in New York City to ban large sugary drinks and a corporate initiative by McDonald’s to provide calorie information on menus.
Date:
November 17, 2025
Type of document:
Cover letter
Manuscript title:
Effectiveness, Adherence, and Safety of Branded Wegovy™ vs. Compounded Semaglutide + Cyanocobalamin (CSC)
Article type:
Original Article
Journal:
The Journal of Obesity and Metabolism
Author:
Shanmugesh Raja, MS
Affiliation:
University of California, San Francisco
Study design:
Retrospective cohort study
Data source:
De-identified telemedicine cohort
Interventions studied:
FDA-approved semaglutide (Wegovy™) and compounded semaglutide + cyanocobalamin
Outcomes assessed:
Weight-loss magnitude and milestones, treatment adherence and persistence, adverse event reporting
Regulatory context:
FDA-approved semaglutide compared with compounded formulation
Conflict of interest disclosure:
Confirmed disclosed
Prior publication status:
Not previously published and not under consideration elsewhere
Year:
203M
Region / City:
N/A
Topic:
Medical Biochemistry, Ketogenesis, Ketoacidosis
Document Type:
Assignment
Institution:
N/A
Author:
N/A
Target Audience:
Medical Students
Period of Action:
N/A
Date of Approval:
N/A
Date of Changes:
N/A
Year:
2017
Region / City:
United States, California
Topic:
Obesity, Diagnostic Imaging, Medical Equipment
Document Type:
Research Paper
Institution:
Centers for Disease Control and Prevention
Author:
Kristin Beinschroth, BSRS, R.T.(R), CRT(R)(F)
Target Audience:
Healthcare Professionals, Radiologists, Medical Equipment Providers
Period of Application:
2017
Approval Date:
Not specified
Revision Date:
Not specified
Year:
2016
Region / City:
Canberra
Theme:
Neonatology, Premature Infant Care
Document Type:
Guideline
Institution:
Canberra Health Services
Author:
Department of Neonatology
Target Audience:
Clinicians (Medical Officers, Registered Nurses, Registered Midwives, Students)
Effective Period:
Ongoing
Approval Date:
Not specified
Revision Date:
Not specified